Indirect effect using ASOs targeting Ataxin-2. An interesting study by Zhang et al. (2018) demonstrated that Ataxin-2 may contribute to the nucleocytoplasmic defects in C9orf72 ALS/FTD through disrupting the stress granule assembly [104]. The gene discussed is C9orf72; the disease is frontotemporal dementia.